Zhejiang Medisen Biopharmaceutical

Zhejiang Medisen Biopharmaceutical is a China-based pharmaceutical company focused on the research, development, and large-scale manufacturing of finished dosage forms and active pharmaceutical ingredients (APIs). The company specializes in several major therapeutic areas, including cardiovascular disease, anti-infectives, and gastrointestinal health, producing a wide range of generic medications such as antihypertensives and statins. Operating out of GMP-certified facilities, Medisen serves both the domestic Chinese market and international clients through its export-oriented manufacturing capabilities. The firm is recognized for its expertise in oral solid dosage forms, including tablets and capsules, and maintains a robust quality management system to meet global regulatory standards.